KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ginkgo Bioworks Holdings (DNA) FCF Margin: 2020-2025

Historic FCF Margin for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Sep 2025 value amounting to -81.38%.

  • Ginkgo Bioworks Holdings' FCF Margin rose 5180.00% to -81.38% in Q3 2025 from the same period last year, while for Sep 2025 it was -103.64%, marking a year-over-year increase of 7404.00%. This contributed to the annual value of -168.31% for FY2024, which is 3456.00% down from last year.
  • Per Ginkgo Bioworks Holdings' latest filing, its FCF Margin stood at -81.38% for Q3 2025, which was down 0.19% from -81.23% recorded in Q2 2025.
  • In the past 5 years, Ginkgo Bioworks Holdings' FCF Margin registered a high of -13.75% during Q3 2021, and its lowest value of -252.92% during Q1 2024.
  • For the 3-year period, Ginkgo Bioworks Holdings' FCF Margin averaged around -141.70%, with its median value being -133.18% (2024).
  • As far as peak fluctuations go, Ginkgo Bioworks Holdings' FCF Margin soared by 14,495bps in 2022, and later slumped by 12,239bps in 2023.
  • Over the past 5 years, Ginkgo Bioworks Holdings' FCF Margin (Quarterly) stood at -114.92% in 2021, then tumbled by 1,752bps to -132.45% in 2022, then slumped by 4,386bps to -176.31% in 2023, then spiked by 4,826bps to -128.05% in 2024, then soared by 5,180bps to -81.38% in 2025.
  • Its FCF Margin was -81.38% in Q3 2025, compared to -81.23% in Q2 2025 and -122.40% in Q1 2025.